Effects of cholesterol and its 24S-OH and 25-OH oxysterols on choline acetyltransferase-positive neurons in brain slices

Pharmacology

Volumn 86, Issue 1, 2010, Pages 15-21

  Ullrich, Celine ^a   Pirchl, Michael ^a   Humpel, Christian ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Department of Psychiatry and Psychotherapy ^*  (Austria)

Author keywords

Cholesterol; Cholinergic neuron; In vitro model; Oxysterols

Indexed keywords

24S HYDROXYCHOLESTEROL; 25 HYDROXYCHOLESTEROL; CHOLESTEROL; CHOLINE ACETYLTRANSFERASE; NERVE GROWTH FACTOR; OXYSTEROL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; MEYNERT BASAL NUCLEUS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; CHOLESTEROL; CHOLINE O-ACETYLTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROXYCHOLESTEROLS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77953674112     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314333     Document Type: Article

References (48)

1. Winkler J, Thal LJ, Gage FH, Fisher LJ: Cholinergic strategies for Alzheimer's disease. J Mol Med 1998; 76: 555-567.
2. Schliebs R, Arendt T: The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm 2006; 113: 1625-1644.
3. Sassin I, Schultz C, Thal DR, Rüb U, Arai K, Braak E, Braak H: Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol 2000; 100: 259-269.
4. Simons M, Keller P, Dichgans J, Schulz JB: Cholesterol and Alzheimer's disease. Neurology 2001; 57: 1089-1093.
5. Puglielli L, Tanzi RE, Kovacs DM: Alzheimer's disease: the cholesterol connection. Nature Neurosci 2003; 6: 345-351.
6. Raffai RL, Weisgraber KH: Cholesterol: from heart attacks to Alzheimer's disease. J Lipid Res 2003; 44: 1423-1430.
7. Bohr IJ: Does cholesterol act as a protector of cholinergic projections in Alzheimer's disease? Lipids Health Dis 2005; 4: 4-13.
8. Reiss AB: Cholesterol and apolipoprotein E in Alzheimer's disease. Am J Alzheimers Dis Other Demen 2005; 20: 91-96.
9. Kivipelto M, Helkala E-L, Hänninen T, Laakso MP, Hallikainen M, Akhainen K, Soininen H, Tuomilehto J, Nissinen A: Midlife vascular risk factors and late-life mild cognitive impairment. Neurology 2001; 56: 1683-1689.
10. Pfrieger FW: Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci 2003; 60: 1158-1171.
11. Xie C, Lund EG, Turley SD, Russell DW, Dietschy JM: Quantification of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration. J Lipid Res 2003; 44: 1780-1789.
12. Bojanic DD, Tarr PT, Gale GD, Smith DJ, Bok D, Chen B, Nusinowitz S, Lövgren-Sandblom A, Björkhem I, Edwards PA: Differential expression and function of ABCG1 and ABCG4 during development and ageing. J Lipid Res 2010; 51: 169-181.
13. Panda T, Devi A: Regulation and degradation of HMGCo-A reductase. Appl Microbiol Biotechnol 2004; 66: 143-152.
14. Goldstein JL, DeBose-Boyd RA, Brown MS: Protein sensors for membrane sterols. Cell 2006; 124: 35-46.
15. Maxfield FR, Tabas I: Role of cholesterol and lipid organization in disease. Nature 2005; 438: 612-621.
16. Björkhem I, Diczfalusy U: Oxysterols. Friends, foes, or just fellow passengers? Arterioscler Thromb Vasc Biol 2002; 22: 734-742.
17. Maxfield FR, Wüstner D: Intracellular cholesterol transport. J Clin Invest 2001; 110: 891-898.
18. Björkhem I, Meaney S, Diczfalusy U: Oxysterols in human circulation: which role do they have. Curr Opin Lipidol 2002; 13: 247-253.
19. Björkhem I: Do oxysterols control cholesterol homeostasis? J Clin Invest 2002; 110: 725-730.
20. Soccio RE, Breslow JL: Intracellular cholesterol transport. Arterioscler Thromb Vasc Biol 2004; 24: 1150-1160.
21. Goldstein JL, DeBose-Boyd RA, Brown MS: Protein sensors for membrane sterols. Cell 2006; 124: 35-46.
22. Sottero B, Gamba P, Garguilo S, Leonarduzzi G, Poli G: Cholesterol oxidation products and disease: an emerging topic of interest in medicinal chemistry. Curr Med Chem 2009; 16: 685-705.
23. Dietschy JM, Turley SD: Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 2004; 45: 1375-1397.
24. Björkhem I, Meaney S: Brain cholesterol: long secret behind a barrier. Arterioscler Thromb Vasc Biol 2004; 24: 806-815.
25. Christ M, Luu B, Mejia JE, Moosbrugger I, Bischoff P: Apoptosis induced by oxysterols in murine lymphoma cells and in normal thymocytes. Immunology 1993; 78: 455-460.
26. Chang JY, Phelan KD, Liu LZ: Neurotoxicity of 25-OH-cholesterol on NGF-differentiated PC12 cells. Neurochem Res 1998; 23: 7-16.
27. Russell DW: Oxysterol biosynthetic enzymes. Biochim Biophys Acta 2000; 1529: 126-135.
28. Schatz DS, Kaufmann WA, Schuligoi R, Humpel C, Saria A: 3,4-Methylenedioxymetamphetamine (ecstasy) induces c-fos-like protein and mRNA in rat organotypic dorsal striatal slices. Synapse 2000; 36: 75-83.
29. Weis C, Marksteiner J, Humpel C: Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic phenotype in organotypic brain slices of the basal nucleus of Meynert. Neuroscience 2001; 102: 129-138.
30. Humpel C, Weis C: Nerve growth factor and cholinergic CNS neurons studied in organotypic brain slices. J Neural Transm 2002; 62: 253-263.
31. Duff K, Noble W, Gaynor K, Matsuoka Y: Organotypic slice cultures from transgenic mice as disease model systems. J Mol Neurosci 2002; 19: 317-320.
32. Zimmer J, Kristensen BW, Jakobson B, Noraberg J: Excitatory amino acid neurotoxicity and modulation of glutamate receptor expression in organotypic brain slice cultures. Amino Acids 2000; 19: 7-21.
33. Gähwiler BH, Hefti F: Guidance of acetylcholinesterase- containing fibers by target tissue in co-cultured brain slices. Neuroscience 1984; 40: 235-243.
34. Gähwiler BH, Capogna M, Debanne D, McKinney RA, Thompson SM: Organotypic slice cultures: a technique has come of age. Trends Neurosci 1997; 20: 471-477.
35. Stoppini L, Buch PA, Muller D: A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 1991; 37: 173-182.
36. Zassler B, Weis C, Humpel C: Tumor necrosis factor-alpha triggers cell death of sensitized potassium chloride-stimulated cholinergic neurons. Mol Brain Res 2003; 113: 78-85.
37. Ullrich C, Humpel C: The pro-apoptotic substance thapsigargin selectively stimulates re-growth of brain capillaries. Curr Neurovasc Res 2009; 6: 171-180.
38. Kristofiková Z, Kopecky V Jr, Hofbauerová K, Hovorková P, Ripová D: Complex of amyloid beta peptides with 24-hydroxycholesterol and its effect on hemicholinium-3 sensitive carriers. Neurochem Res 2008; 33: 412-421.
39. Björkhem I: Are side-chain oxidized oxysterols regulators also in vivo? J Lipid Res 2009; 50: 213-218.
40. Baldán Á, Bojanic DD, Edwards PA: The ABCs of sterol transport. J Lipid Res 2009; 50: 80-85.
41. Baranowski M: Biological role of liver X receptors. J Physiol Pharmacol 2008; 59: 31-55.
42. Kim WS, Rahmanto AS, Kamili A, Rye KA, Guillemin GJ, Gelissen IC, Jessup W, Hill AF, Garner B: Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid- peptide generation. J Biol Chem 2007; 282: 2851-2861.
43. Kölsch H, Ludwig M, Lütjohann D, Rao ML: Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17- . J Neural Transm 2001; 108: 475-488.
44. Trousson A, Bernard S, Petit PX, Liere P, Pianos A, El Hadri K, Lobaccaro J-MA, Ghandour MS, Raymondjean M, Schumacher M, Massaad C: 25- hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR. J Neurochem 2009; 109: 945-958.
45. Lemaire-Ewing S, Prunet C, Montange T, Vejux A, Berthier A, Bessède G, Corcos L, Gambert P, Néel D, Lizard G: Comparison of the cytotoxic, prooxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol Toxicol 2005; 21: 97-114.
46. Joffre C, Leclère L, Buteau B, Martine L, Cabaret S, Malvitte L, Acar N, Lizard G, Bron A, Creuzot-Garcher C, Bretillon L: Oxysterols induced inflammation and oxidation in primary porcine retinal pigment epithelial cells. Curr Eye Res 2007; 32: 271-280.
47. Hong C, Tontonoz P: Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Curr Opin Genet Dev 2008; 18: 461-467.
48. Gueguen Y, Bertrand P, Ferrari L, Batt AM, Siest G: Control of apolipoprotein E secretion by 25-hydroxycholesterol and proinflammatory cytokines in the human astrocytoma cell line CCF-STTG1. Cell Biol Toxicol 2001; 17: 191-199.